DOCSLIB.ORG

Science Driven by the Market Tio2 Producer Sachtleben for €97.5 Million to Its Joint Venture Partner, US Holding Rockwood

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Science Driven by the Market Tio2 Producer Sachtleben for €97.5 Million to Its Joint Venture Partner, US Holding Rockwood 3/2013 March REACH Chemicals The European Commission’s THE NEWSPAPER FOR THE Combining performance and REACh Review received a mixed sustainability is the big deal response from industry and NGOs CHEMICAL AND in the coatings sector © Tanja Bagusat - Fotolia.com LIFE SCIENCE MARKETS © frank peters - Fotolia.com Page 4 Pages 9–11 N EWSFLOW M&A-News Kemira sold its 39% stake in German Science Driven By the Market TiO2 producer Sachtleben for €97.5 million to its joint venture partner, US holding Rockwood. CEO Patrick Thomas Takes a New Approach to Innovation at BMS Monsanto acquires Israeli crop bio-engineering company Rosetta Materials – When new company he had to convince the Bayer hold- Green for $35 million. ing’s chief financial officer that the chieftains say they want to be a cata- More on Pages 2-7 ▶ targets were achievable. Over six lyst for change, many listeners brush it years, Thomas and his financial Companies off as a tired cliché. Patrick Thomas is team have reduced working capital Evonik is taking aim at a stock mar- by €500 million, and “we now have ket launch for the fourth time since proof that it needn’t be. Stepping into benchmark working capital across 2008. After the aborted attempt in his new role as chairman and CEO of the entire company.” June 2012 to publicly place 30% of A pet project of the new chief ex- Bayer MaterialScience (BMS) in 2007, shares, observers now give the Ger- ecutive was establishing strict cash man specialty chemicals company the then 49-year-old Englishman who Our mantra is discipline, which turned out not as better odds of succeeding. previously had led the polyurethanes more innovation, easy a sell internally as it might have More on Page 3 ▶ been. The reason, Thomas believes, businesses of ICI and Huntsman in the less administration. was that “at a company like Bayer Investments UK and Belgium quickly went to work with a fabulous credit rating, it was not a natural thing to think about.” Shell is upgrading its Singapore holding the old German company’s production facility for polyols by But coming from a highly leveraged more than 100,000 t/y and adding cherished traditions and practices up company like Huntsman, he found new grades. The project is due for to the light for scrutiny while contem- it essential. “If you manage cash completion in 2014. well, you can manage other things plating new business models. well.” Over the past decade, Bayer’s More on Pages 3-7▶ polymers business has generated €3 billion in cash. Unlike some plastics Pharma After six years in the job, many chief companies, “we have been cash pos- Biogen is paying its Irish partner executives might be tempted to de- itive even in recession years.” Elan $3.25 billion plus future royal- clare “Mission Accomplished” and A new concept Thomas’s man- ties to claim full ownership of the fall back into a more comfortable agement team has introduced is blockbuster multiple sclerosis drug operating mode. This thought would the global “non-touch order,” which Tysabri. not occur naturally to Patrick Thom- if one day applied broadly could Lonza has been awarded a contract as. The Portsmouth native and Ox- revolutionize buying and selling. to generate induced pluripotent ford graduate who calls himself “an From call-off to invoicing and cash stem cells for research purposes engineer by birth and by training” collection, no human hand touches by the U.S. National Institutes of is still far from finished reshaping the process. For the bulk of the port- Health Center for Regenerative folio, total automation is not yet in Medicine. the polymer producer’s approach to innovation and marketing – two Patrick Thomas, CEO, Bayer MaterialScience sight. However, in the US, where More on Pages 3-7 ▶ concepts that in his mind go hand the system was developed and first in hand. ade. “You cannot radically change vesting heavily, for example, in ber of innovative new technologies launched, around 60% of custom- Collaborations Having scarcely paused to catch the culture of a 150-year-old com- China”. In the past, all businesses developed in-house, such as the ers who regularly order the same Richter, the Hungarian drug maker, his breath since arriving in Lev- pany,” he remarks. “What we’ve ba- were run from Germany. Under his gas-phase route to polyurethane products, without price negotiation has formed a 51:49 marketing joint erkusen, Thomas blogs relentlessly, sically done is to take Bayer’s tech- aegis, headquarters of the global feedstock TDI and the new energy- – polyurethane systems, for example venture in China with its marketing sparking dialog throughout the Bay- nical dreams and push them out into polycarbonate business was relo- saving oxygen depolarized cathode – are now using it. partner Rxmidas Pharmaceuticals. er worldwide social media commu- reality.” cated to the People’s Republic, the (ODC) chlorine process. “We had the process designed in More on Page 3 ▶ nity. Covering topics ranging from At BMS, polycarbonate, polyure- center of the market. One of the last Before making bold strategic the US, because Americans are usu- finance to sustainability and points thanes and their production chains, to launch a major platform there, moves, new managers often must ally more efficient,” says Thomas. Southeast Asia in between, his community, simply along with coatings raw materials, “we are now the largest foreign tighten internal nuts and bolts. Sev- Europeans might have made it too The regional focus in this issue called “Patrick” has 14,000 follow- are the stuff technical dreams are eral such tasks awaited Thomas at complex.” Around 20-30% of Eu- highlights the emerging econo- ers – the most in the company. “It’s made of. The €11.5 billion plastics Bayer MaterialScience. Overhaul- ropean and Asian customers have mies of Southeast Asia. an effective way of communicating,” portfolio, custom-designed when About 70% of ing accounting procedures was an now adapted the system, 12% in while sitting in his office and chat- Bayer’s plastics business was split early challenge. “We had the most Latin America. Besides simplifying More on Pages 6, 8 ▶ ting with CHEManager Europe’s between MaterialScience and spin- what scientists do complicated SAP system in the and speeding orders, the system is Dede Williams. Since mid-2011, off Lanxess in 2005, was “put to- should be driven world,” he recalls. The world mar- cheaper for the company as well as Plastics Thomas has also dedicated a por- gether very intelligently,” the CEO ket leader for company software the customers, he says. The bonan- Polyvinyl Chloride (PVC) has come by the market. tion of his seemingly boundless en- says. BMS kept the two most ver- usually uses traffic light colors to za in Asia was especially tangible. a long way since its inventor in ergy to another “interesting job” as satile polymers, with bread and rate internal corporate procedures. “When we went live, the auditors 1913. PVC’s journey to becoming president of the European industry butter materials such as PA , PBS company, wholly owned, with a “For us they had to add a fourth reduced our bill by several million the world’s third largest-selling association Plastics Europe (until and ABS (the latter business sub- market capitalization of $3 billion. color, black, for processes they dollars because we made their job plastic has not always been easy. June 2014). sequently was sold to Ineos) going And we’re also “the biggest and couldn’t interpret.” Today, BMS easier. The money saved is being in- More on Pages 12-14 ▶ Sipping Diet Coke from a polycar- to Lanxess. most cost-effective.” operates with one set of processes vested in R&D.” bonate glass while scrolling through “From the outset, BMS was de- New processes are now often globally. Regional differences are a As might be expected, BMS’ his laptop to find a video of a high signed as a growth business, and tested first in world-scale plants in thing of the past. approach to R&D under its Eng- tech application he wants to show, this is what what we have contin- China before world-scale facilities Another hurdle the first outsider lish chief executive diverges from Thomas reflects on the gentle cul- ued to do with it,” says Thomas. To are built in Europe and the rest of and non-German to run the com- that traditionally embraced by the tural metamorphosis at Bayer Ma- start with, “we have broadened the the world. in this way, the company pany had to surmount was reduc- German chemical and plastics in- terialScience over the past half dec- geographical basis enormously, in- has successfully leveraged a num- ing working capital. First, however, dustry. “Our mantra,” he says, is “more innovation, less administra- tion. Innovation is not just science and technology. It’s also about how you do business.” Applying one of his cherished concepts, industrial THE PORTAL AND marketing, to innovation at BMS DECISIVE NEWSPAPER FOR three years ago was a sea change INFORMATION and a learning process for most THE EUROPEAN employees. CHEMICALS AND “At Bayer, we are very good at chemanager - online.com /en invention,” Thomas asserts. While PHARMACEUTICAL manufacturers’ traditional approach MARKETS to invention is “to develop a prod- © Nmedia/fotolia uct and see if there’s a market, a better method, he says, is to go to the marketplace to find creative im- pulses that match the portfolio and · PF 11 05 64 · 69469 Weinheim · Pressepost · DPAG· Entgelt bezahlt · 78719 Entgelt · DPAG· · Pressepost Weinheim · PF 11 05 64 69469 business strategy.
Load more

Recommended publications
  • The Life Cycle of Sterling Drug, Inc.*
    22 Bull. Hist. Chem., VOLUME 25, Number 1 (2000) THE LIFE CYCLE OF STERLING DRUG, INC.* Joseph C. Collins and John R. Gwilt The foundations of Sterling Drug were laid by William partners were bought out. Weiss and Diebold realized E. Weiss and Albert H. Diebold, boyhood friends in that expansion required more product lines and that these Canton, Ohio. Weiss graduated from the Philadelphia would best be obtained by acquisition. This policy con- College of Pharmacy in 1896 and went to work in a tinued throughout the life of the organization, at least drug store in Sistersville, West Virginia. Diebold raised 130 companies being acquired, directly or indirectly, funding from his father’s company, Diebold Safe and Lock, and in 1901 the friends set up business together in Wheeling, WV. In fact, Sterling operated a plant in that town until 1962. The history of the Corporation can conveniently be divided into five periods: 1901-1917 The Neuralgyline Period 1917-1928 Sterling Products I 1928-1933 Drug Inc. 1933-1942 Sterling Products II 1942-1988 Sterling Drug, Inc. The Neuralgyline Period On May 4, 1901, Weiss and Diebold, with three local business men as partners, established the Neuralgyline Company with the sole purpose of manufacturing and Figure 1. Where it all began: in 1901 the selling a pain-relieving preparation which they called Neuralgyline Company occupied two upstairs rooms “Neuralgine.” There is now no company record of its in this house in Wheeling, WV. composition, but it seems to have been a mixture of ac- from 1902 through 1986. Ironically, the eventual fate etanilide, caffeine, and sodium salicylate.
    [Show full text]
  • I.G. Farben's Petro-Chemical Plant and Concentration Camp at Auschwitz Robert Simon Yavner Old Dominion University
    Old Dominion University ODU Digital Commons History Theses & Dissertations History Summer 1984 I.G. Farben's Petro-Chemical Plant and Concentration Camp at Auschwitz Robert Simon Yavner Old Dominion University Follow this and additional works at: https://digitalcommons.odu.edu/history_etds Part of the Economic History Commons, and the European History Commons Recommended Citation Yavner, Robert S.. "I.G. Farben's Petro-Chemical Plant and Concentration Camp at Auschwitz" (1984). Master of Arts (MA), thesis, History, Old Dominion University, DOI: 10.25777/7cqx-5d23 https://digitalcommons.odu.edu/history_etds/27 This Thesis is brought to you for free and open access by the History at ODU Digital Commons. It has been accepted for inclusion in History Theses & Dissertations by an authorized administrator of ODU Digital Commons. For more information, please contact [email protected]. 1.6. FARBEN'S PETRO-CHEMICAL PLANT AND CONCENTRATION CAMP AT AUSCHWITZ by Robert Simon Yavner B.A. May 1976, Gardner-Webb College A Thesis Submitted to the Faculty of Old Dominion University in Partial Fulfillment of the Requirements for the Degree of MASTER OF ARTS HISTORY OLD DOMINION UNIVERSITY August 1984 Approved by: )arw±n Bostick (Director) Reproduced with permission of the copyright owner. Further reproduction prohibited without permission. Copyright by Robert Simon Yavner 1984 All Rights Reserved Reproduced with permission of the copyright owner. Further reproduction prohibited without permission. ABSTRACT I.G. FARBEN’S PETRO-CHEMICAL PLANT AND CONCENTRATION CAMP AT AUSCHWITZ Robert Simon Yavner Old Dominion University, 1984 Director: Dr. Darwin Bostick This study examines the history of the petro­ chemical plant and concentration camp run by I.G.
    [Show full text]
  • BAYER FOUNDATIONS Fellowship Program FOCUS on Education and Research BAYER Fellowship Program 2|3
    Bayer: Science For A Better Life BAYER FOUNDATIONS FELLOWSHIP PROGRAM FOCUS ON EDUCATION AND RESEARCH BAYER FELLOWSHIP PROGRAM 2|3 The Bayer Science & Education Foun­ dation For the inventor company Bayer, young up-and- coming talents as well as scientific progress are fundamental to long-term success. The Bayer Science & Education Foundation therefore supports people – schoolchildren, students or top scientists – who are fascinated by science, medicine and technology. Our aim is to awake inventive spirit, expand educational horizons and honor outstanding achievements in science and education. The foundation promotes innovation on all levels: the spectrum ranges from the funding of school projects to scholarships and scientific awards, with a particular focus on health care, nutrition and high-tech materials. The foundation’s activities are inspired by the Bayer Group’s mission statement: Bayer: Science For A Better Life Further information at: www.bayer­foundations.com SUPPORT FOR YOUNG TALENTS FELLOWSHIP PROGRAM Benjamin Buick, physics student, gained valuable experience through his scholarship from the Bayer foundation for an internship at the Tor Vergata University of Rome, Italy. BAYER FELLOWSHIP PROGRAM 4|5 The foundation’s scholarship programs have two main areas of focus – the regular programs for scholarship projects and placements abroad, and additional offerings aimed at specific target groups. The regular programs are setup for students, trainees and apprentices in scientific, technical and medical disciplines. Internationality is a key aspect of these programs. Therefore the founda- tion grants scholarships exclusively to applicants from German-speaking countries wishing to go abroad and to foreign applicants who are inter- ested in a study project in Germany.
    [Show full text]
  • The Persistence of Elites and the Legacy of I.G. Farben, A.G
    Portland State University PDXScholar Dissertations and Theses Dissertations and Theses 5-7-1997 The Persistence of Elites and the Legacy of I.G. Farben, A.G. Robert Arthur Reinert Portland State University Follow this and additional works at: https://pdxscholar.library.pdx.edu/open_access_etds Part of the History Commons Let us know how access to this document benefits ou.y Recommended Citation Reinert, Robert Arthur, "The Persistence of Elites and the Legacy of I.G. Farben, A.G." (1997). Dissertations and Theses. Paper 5302. https://doi.org/10.15760/etd.7175 This Thesis is brought to you for free and open access. It has been accepted for inclusion in Dissertations and Theses by an authorized administrator of PDXScholar. Please contact us if we can make this document more accessible: [email protected]. THESIS APPROVAL The abstract and thesis of Robert Arthur Reinert for the Master of Arts in History were presented May 7, 1997, and accepted by the thesis committee and department. COMMITTEE APPROVALS: Sean Dobson, Chair ~IReard~n Louis Elteto Representative of the Office of Graduate Studies DEPARTMENT APPROVAL: [)fl Dodds Department of History * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ACCEPTED FOR PORTLAND STATE UNIVERSITY BY THE LIBRARY by on ct</ ~~ /997 ABSTRACT An abstract of the thesis of Robert Arthur Reinert for the Master of Arts in History presented May 7, 1997. Title: The Persistence of Elites and the Legacy of LG. Farben, A.G .. On a massive scale, German business elites linked their professional ambitions to the affairs of the Nazi State. By 1937, the chemical giant, l.G. Farben, became completely "Nazified" and provided Hitler with materials which were essential to conduct war.
    [Show full text]
  • BAYER FOUNDATIONS Fellowship Program Veterinary Student in Action
    Bayer: Science For A Better Life BAYER FOUNDATIONS FELLOWSHIP PROGRAM Veterinary student in action. in student Veterinary BAYER FELLOWSHIP PROGRAM 2| 3 PIONEERS IN Bayer Foundations – SCIENCE & SOCIETY Partner of Pioneers Since 1897 The Bayer Foundations have been acting as catalysts COMMITMENT for societal progress and frontier innovations ever since Friedrich Bayer Junior laid the basis for first TO PROGRESS activities in 1897. Today, two corporate foundations support pioneers all around the globe in six program areas ranging from frontier science to social innovation in health and agriculture related topics. The Bayer Science & Education Foundation supports frontier research, talent development and science education in three program areas: In the Science@School program the foundation promotes science teachers who carry the spirit of innovation into the classroom and make young people feeling the fascination of sciences. In the Bayer Fellowship program the foundation enables outstanding talents to undertake out-of-the-box international study and research projects in scientific areas related to health and agriculture. With Science Awards the foundation honors frontier research and supports rising stars in life sciences, chemistry and medicine. Along with the scientific programs of the Bayer Science & Education Foundation, the Bayer Cares Foundation supports new solutions for societal challenges related to health and agriculture. The focus is on passionate people who are closing gaps in society through volunteer work and social innovations. In addition, the foundation is engaged in relief and reconstruction projects following natural disasters. More information at: Both foundations share Bayer’s ultimate goal: www.bayer-foundations.com improving human life through innovation. BAYER FELLOWSHIP PROGRAM 4|5 Bayer Fellowship program – support talents to grow The Bayer fellowship program supports extraor- PROMOTING PIONEERS dinary gifted talents in order to help them realize OF TOMORROW individual study and research projects abroad.
    [Show full text]
  • PDF Viewing Archiving 300
    I.C.FARBEN­ INDUSTRIE AKTIEN~ GESELLSCHAFT FRANKFURT(.MAIN) 1 9 3 2 L G. Farbenindustrie Aktiengesellschaft Frankfurt (Main) Bericht· des Vorstandes und des Aufsichtsrates über das Geschäftsjahr 1932. 8. ordentliche Generalversammlung Freitag, den 28. April 1933, vormittags 11 Uhr, in unserem Verwaltungsgebäude Frankfurt (Main) Grüneburgplatz. Tages-Ordnung: 1. Vorlage des Jahresabschlusses und des Geschäftsberichtes für 1932 und Beschlußfassung über den Jahresabschluß. 2. Gewinnverteilung. 3. Entlastung des Aufsichtsrates und des Vorstandes. 4. Wahlen zum Aufsichtsrat. 5. Wahl des Bilanzprüfers fUr das Geschäftsjahr 1933. Aufsi chtsrat. Geheimer Regierungsrat Professor Dr. CARL DUISBERG, Leverkusen, Vorsitzender, Dr. CARL von WEINBERG, Frankfurt (Main)-Niederrad, stellvertretender Vorsitzender, Dr. WTLHELM FERDINAND KALLE, Frankfurt (Main), Dr. RUDOLF MANN, Leverkusen, Verwaltungsrat Geheimer Kommerzienrat Dr. LUDWIG SCHUON, München, Staatssekretär z. D. Dr. ERNST von SIMSON, Berlin-Dahlem, Geheimer Regierungsrat Dr. ARTHUR von WEINBERG, Frankfurt (Main)-Niederrad. J Dr. WALTHER vom RATH, Cronberg (Taunus), Kommerzienrat ADOLF KÄCHELEN, Stuttgart, stellvertretender Vorsitzender, Wirkt. Geheimer Oberregierungsrat Dr. WILHELM von Dr. AXEL AUBERT, Oslo. MEISTER, Regierungspräsident a. D., Genf. Geheimer Hofrat Dr. GUST AV AUFSCHLÄGER, Hamburg, OTTO von MENDELSSOHN-BARTHOLDY, Berlin, Dr. RICHARD BAYER, Leverkusen, Dr. ALFRED MERTON, Frankfurt (Main), WALDEMAR von BöTTINGER, Rittergutsbesitzer, WILHELM PELTZER, Fabrikant, Krefeld, Schloss Arensdorf i. d. Neumark, Dr. W ALTER von BRONING, Polizeipräsident a. D., JULIUS SCHARFF, Bad Liebenzell, Semper a. Rügen, Graf RUTGER JAN EUGEN SCHIMMELPENNINCK, Kommerzienrat LOTHAR BRUNCK, Kirchheimbolanden, Den Haag (Holland), Geheimer Kommerzienrat Dr. LEO GANS, Dr. OSCAR SCHLITTER, Berlin, Frankfurt (Main), Geheimer Regierungsrat Dr. ADOLF HAEUSER, Staatsminister Dr. FRIEDRICH SCHMIDT -OTT, Frankfurt (Main), Exzellenz, Berlin-Steglitz, Dr. JAKOB HASSLACHER, Duisburg-Ruhrort, LEOPOLD Freiherr von SCHRENCK-NOTZING, Berlin.
    [Show full text]
  • Bayer Foundations Fellowship Program Bayer Fellowship Program 2| 3
    Bayer: Science For A Better Life BAYER FOUNDATIONS FELLOWSHIP PROGRAM BAYER FELLOWSHIP PROGRAM 2| 3 Bayer Science & Education Foundation – commitment to progress WORLD TALENTS In a world of constant change, progress in science and society is more than ever the key prerequisite FRONTIER RESEARCH for mastering the challenges of the future. Particularly for an innovation company like Bayer, excellence in science and education builds the foundation for long-term success. This is why the Bayer foundation has been support- ing pioneering spirit in science and society since 18 97. The scientific programs of the foundation encour- age creativity and inventive spirit in science and medicine – on all educational levels: the current support spectrum ranges from school projects and scholarship programs to a variety of scientific achievement awards. All programs are inspired by Bayer’s mission: Science For A Better Life! More information at: www.bayer-foundations.com BAYER FELLOWSHIP PROGRAM 4|5 Bayer Foundations Fellowship – help talents to grow INSPIRING KNOWLEDGE – The international fellowship program of the Bayer Science & Education Foundation supports ENCOURAGING TALENTS extraordinarily gifted talents in order to help them realize individual study and research projects abroad. Scholarships for individual applications: Otto Bayer Scholarship: natural sciences Carl Duisberg Scholarship: medicine Jozef Schell Scholarship: agro sciences Kurt Hansen Scholarship: science teachers Hermann Strenger Scholarship: apprentices Scholarships are granted exclusively
    [Show full text]
  • One Hundred Years of Chemical Warfare: Research
    Bretislav Friedrich · Dieter Hoffmann Jürgen Renn · Florian Schmaltz · Martin Wolf Editors One Hundred Years of Chemical Warfare: Research, Deployment, Consequences One Hundred Years of Chemical Warfare: Research, Deployment, Consequences Bretislav Friedrich • Dieter Hoffmann Jürgen Renn • Florian Schmaltz Martin Wolf Editors One Hundred Years of Chemical Warfare: Research, Deployment, Consequences Editors Bretislav Friedrich Florian Schmaltz Fritz Haber Institute of the Max Planck Max Planck Institute for the History of Society Science Berlin Berlin Germany Germany Dieter Hoffmann Martin Wolf Max Planck Institute for the History of Fritz Haber Institute of the Max Planck Science Society Berlin Berlin Germany Germany Jürgen Renn Max Planck Institute for the History of Science Berlin Germany ISBN 978-3-319-51663-9 ISBN 978-3-319-51664-6 (eBook) DOI 10.1007/978-3-319-51664-6 Library of Congress Control Number: 2017941064 © The Editor(s) (if applicable) and The Author(s) 2017. This book is an open access publication. Open Access This book is licensed under the terms of the Creative Commons Attribution-NonCommercial 2.5 International License (http://creativecommons.org/licenses/by-nc/2.5/), which permits any noncom- mercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. The images or other third party material in this book are included in the book's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the book's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
    [Show full text]
  • Asm-2015-Countermotions-En.Pdf
    Countermotions for the BAYER Annual Stockholders' Meeting on May 27, 2015 This notice is a convenience translation. For the legally binding document, please refer to the original German version which is published on the Internet at http://www.bayer.de/de/gegenantraege-2015.aspx May 12, 2015 18:54 HP LASERJET FAX P.1 Bayer AG, Annual Stockholders' Meeting on May 27, 2015 in Cologne Countermotion of stockholder Michael Wolff, Neustadt, to item 5 Section 2, Paragraph 1 of the Articles of Incorporation shall be worded as follows: "The Object of the Company is manufacturing, marketing and other industrial activities or the provision of services in the fields of health care, environmental protection and agriculture. The Company may also perform these activities in the fields of polymers and chemicals." Reasoning: The future focus of the Bayer Group on the Life Science businesses of HealthCare and CropScience makes it necessary and expedient, especially against the backdrop of the imminent separation of MaterialScience, to take sustainable account of environmental protection. In view of changing economic circumstances HealthCare and CropScience are dependent on sustainable development. Business activity must be sustainable and environmentally compatible. In this context, the pesticides endangering bees containing the harmful neurotoxin thiacloprid (e.g. “Calypso Schädlingsfrei” and “Lizetan Zierpflanzenspray”), which only have a relatively low share of sales in the Bayer Group, should be removed from the market immediately. The legal action brought before the European Court of Justice regarding the neonicotinoid active ingredients clothianidin, thiomethoxam and imidacloprid banned by the European Commission should be withdrawn. For bees, orientation ability and – nicotine-free – communication are essential for survival.
    [Show full text]
  • The First Miracle Drugs : How the Sulfa Drugs Transformed Medicine
    The First Miracle Drugs: How the Sulfa Drugs Transformed Medicine JOHN E. LESCH OXFORD UNIVERSITY PRESS The First Miracle Drugs This page intentionally left blank THE FIRST MIRACLE DRUGS How the Sulfa Drugs Transformed Medicine JOHN E. LESCH 1 2007 3 Oxford University Press, Inc., publishes works that further Oxford University’s objective of excellence in research, scholarship, and education. Oxford New York Auckland Cape Town Dar es Salaam Hong Kong Karachi Kuala Lumpur Madrid Melbourne Mexico City Nairobi New Delhi Shanghai Taipei Toronto With offices in Argentina Austria Brazil Chile Czech Republic France Greece Guatemala Hungary Italy Japan Poland Portugal Singapore South Korea Switzerland Thailand Turkey Ukraine Vietnam Copyright © 2007 by John E. Lesch Published by Oxford University Press, Inc. 198 Madison Avenue, New York, New York 10016 www.oup.com Oxford is a registered trademark of Oxford University Press All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior permission of Oxford University Press. Library of Congress Cataloging-in-Publication Data Lesch, John E. [date] The first miracle drugs : how the sulfa drugs transformed medicine / John E. Lesch. p. ; cm. Includes bibliographical references and index. ISBN-13 978-0-19-518775-5 ISBN 0-19-518775-X 1. Sulphonamides—Therapeutic use—History. 2. Antibacterial agents—History. I. Title. [DNLM: 1. Sulfonamides—history. 2. Bacterial Infections—drug therapy. 3. History, 20th Century. 4. Sulfonamides—therapeutic use. QV 265 L625f 2006] RM666.S88L47 2006 615'.32938—dc22 2005036136 987654321 Printed in the United States of America on acid-free paper For Paula This page intentionally left blank Preface e live in an age of powerful medicinal drugs.
    [Show full text]
  • James, Steinhauser, Hoffmann, Friedrich One Hundred Years at The
    James, Steinhauser, Hoffmann, Friedrich One Hundred Years at the Intersection of Chemistry and Physics Published under the auspices of the Board of Directors of the Fritz Haber Institute of the Max Planck Society: Hans-Joachim Freund Gerard Meijer Matthias Scheffler Robert Schlögl Martin Wolf Jeremiah James · Thomas Steinhauser · Dieter Hoffmann · Bretislav Friedrich One Hundred Years at the Intersection of Chemistry and Physics The Fritz Haber Institute of the Max Planck Society 1911–2011 De Gruyter An electronic version of this book is freely available, thanks to the support of libra- ries working with Knowledge Unlatched. KU is a collaborative initiative designed to make high quality books Open Access. More information about the initiative can be found at www.knowledgeunlatched.org Aut ho rs: Dr. Jeremiah James Prof. Dr. Dieter Hoffmann Fritz Haber Institute of the Max Planck Institute for the Max Planck Society History of Science Faradayweg 4–6 Boltzmannstr. 22 14195 Berlin 14195 Berlin [email protected] [email protected] Dr. Thomas Steinhauser Prof. Dr. Bretislav Friedrich Fritz Haber Institute of the Fritz Haber Institute of the Max Planck Society Max Planck Society Faradayweg 4–6 Faradayweg 4–6 14195 Berlin 14195 Berlin [email protected] [email protected] Cover images: Front cover: Kaiser Wilhelm Institute for Physical Chemistry and Electrochemistry, 1913. From left to right, “factory” building, main building, director’s villa, known today as Haber Villa. Back cover: Campus of the Fritz Haber Institute of the Max Planck Society, 2011. The Institute’s his- toric buildings, contiguous with the “Röntgenbau” on their right, house the Departments of Physical Chemistry and Molecular Physics.
    [Show full text]
  • The Dynamics of German Cartels and Patents. I*
    THE DYNAMICS OF GERMAN CARTELS AND PATENTS. I* HmmE cH KR NsEnmt N TWO articles, of which this is the first, I shall discuss the develop- ment of cartels in Germany and their relation to patents. The fol- lowing questions will receive primary consideration: i. Why did Germany become the homeland of the cartels and the prin- cipal exporter of technology? 2. What has been accomplished by and with the cartels in the different stages of development? 3. What was the significance of patents in the development of the cartel device? 4. What was the effect of these cartels on the state and society in the several stages of development? 5. How did the German government react to the development of car- tels and the use of the patent device in the several stages of development? 6. What was the reaction of other countries to the German cartel and patent system? 7. How did Hitler utilize the cartel and patent system for the purpose of preparing for and waging the war? 8. How did he use especially the obligations assumed by firms outside of Germany, to German firms, for his purpose? I am not going to answer all these questions, but I hope to contribute something to the understanding of the phenomenon under discussion. DEVELOPMENT BEFOR~E 11ITLET Cartels and other forms of monopoly power may be considered from the point of view of their legal aspects (internal organization and relations to actual or prospective contractees and governmental authorities) or from the point of view of their economic aspects (effect on prices, wages and * This article was the basis of the writer's testimony before the Senate Patent Committee.
    [Show full text]